NCT05577689Recruiting
Novel Therapy Target in Metastatic Prostate Cancer
Combining Multi-omics Analysis and Organoid Models to Search for Novel Therapy Target in Metastatic Prostate Cancer
Source: ClinicalTrials.gov · Last updated 5 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to use multiomics sequencing to explore the molecular characteristics of metastatic prostate cancer (mPCa), especially metastatic castration-resistant prostate cancer (mCRPC). At the same time, mCRPC models will be constructed, including organoids and animal models, serving as a basic and translational research platform to help identify novel drug targets for mPCa.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 10 Oct 2022
- Start date
- 1 Aug 2023
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- Fudan University
- Diseases
- Prostate cancer
- NCT number
- NCT05577689
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Aug 2023 to the primary completion date, 1 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not accessible to surgery sample
Other illness
- Patients diagnosed with other types of cancer besides prostate cancer
Other
- Patients fail to provide informed consent
- Other situation that researchers think are unsuitable for this study
Who the study is looking for
- Histologically confirmed prostate cancer
- metastatic disease confirmed by image examination
- Patients who can undergo surgery or biopsy for prostate cancer
- Able to provide informed consent
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fudan University Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.